Safety of mRNA-based vaccines against SARS-CoV-2 in people with cystic fibrosis aged 12 years and over.
作者信息
Alicandro Gianfranco, Daccó Valeria, Cariani Lisa, Contarini Martina, Morlacchi Letizia Corinna, Rosazza Chiara, Sciarrabba Calogero Sathya, Ferraro Federica, Lanfranchi Chiara, Orena Beatrice Silvia, Gramegna Andrea, Blasi Francesco, Colombo Carla
机构信息
Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Italy; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Cystic Fibrosis Centre, Milan, Italy.
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Cystic Fibrosis Centre, Milan, Italy.
出版信息
J Cyst Fibros. 2022 May;21(3):e173-e175. doi: 10.1016/j.jcf.2022.02.009. Epub 2022 Feb 16.
Abstract
摘要
相似文献
1
Safety of mRNA-based vaccines against SARS-CoV-2 in people with cystic fibrosis aged 12 years and over.12岁及以上囊性纤维化患者中基于mRNA的SARS-CoV-2疫苗的安全性。
J Cyst Fibros. 2022 May;21(3):e173-e175. doi: 10.1016/j.jcf.2022.02.009. Epub 2022 Feb 16.
2
Successful mRNA SARS-Cov-2 vaccine rechallenge after a first episode of immune thrombocytopenic purpura.在首次发生免疫性血小板减少性紫癜后成功进行mRNA SARS-CoV-2疫苗再次接种。
Platelets. 2022 May 19;33(4):652-653. doi: 10.1080/09537104.2022.2044463. Epub 2022 Feb 28.
3
Prior SARS-CoV-2 infection increases reactogenicity after SARS-COV-2 mRNA vaccine and could delay the administration of the vaccine based on timing of infection.既往感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）会增加接种SARS-CoV-2信使核糖核酸（mRNA）疫苗后的反应原性，并可能根据感染时间延迟疫苗接种。
Infection. 2022 Jun;50(3):791-793. doi: 10.1007/s15010-021-01729-z. Epub 2021 Dec 2.
4
Immediate reactions after mRNA SARS-CoV-2 vaccination.新型冠状病毒mRNA疫苗接种后的即时反应。
CMAJ. 2021 Dec 6;193(48):E1842. doi: 10.1503/cmaj.211581. Epub 2021 Nov 12.
5
Early experience of COVID-19 vaccine-related adverse events among adolescents and young adults with rheumatic diseases: A single-center study.青少年和年轻成年人风湿性疾病患者 COVID-19 疫苗相关不良事件的早期经验：一项单中心研究。
Int J Rheum Dis. 2022 Mar;25(3):353-363. doi: 10.1111/1756-185X.14279. Epub 2022 Jan 3.
6
Meta-Analysis of Risk of Myocarditis After Messenger RNA COVID-19 Vaccine.信使核糖核酸新冠疫苗接种后心肌炎风险的Meta分析
Am J Cardiol. 2022 Mar 15;167:155-157. doi: 10.1016/j.amjcard.2021.12.007. Epub 2022 Jan 19.
7
Definite Acute Myocarditis After Coronavirus Disease 2019 mRNA Vaccination.2019冠状病毒病mRNA疫苗接种后确诊的急性心肌炎
Circ J. 2022 Mar 25;86(4):724. doi: 10.1253/circj.CJ-21-0840. Epub 2021 Dec 4.
8
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.COVID-19 疫苗：辉瑞/生物科技和 Moderna 疫苗的生物学、药理学特征和不良反应比较。
Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877.
9
Coronavirus disease 2019 messenger RNA vaccine skin tests and serum histamine levels in allergic reactions.2019冠状病毒病信使核糖核酸疫苗皮肤试验及过敏反应中的血清组胺水平
Ann Allergy Asthma Immunol. 2022 Mar;128(3):339. doi: 10.1016/j.anai.2021.12.014.
10
Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine.SARS-CoV-2 ARCoV mRNA疫苗的安全性和免疫原性。
Lancet Microbe. 2022 Aug;3(8):e561. doi: 10.1016/S2666-5247(22)00150-1. Epub 2022 May 31.
引用本文的文献
1
The efficacy of COVID-19 vaccination in cystic fibrosis patients: a systematic review.新冠疫苗对囊性纤维化患者的疗效：一项系统评价。
BMC Infect Dis. 2025 Mar 13;25(1):358. doi: 10.1186/s12879-025-10736-6.
2
Immunogenicity of the COVID-19 BNT162b2 vaccine in adolescents and young adults with cystic fibrosis.COVID-19 BNT162b2 疫苗在囊性纤维化青少年和年轻成人中的免疫原性。
J Cyst Fibros. 2022 May;21(3):e184-e187. doi: 10.1016/j.jcf.2022.04.004. Epub 2022 Apr 14.
Zotero 插件